9
Apr
2025

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd

Exhibitor at CPHI Japan 2025 stand 5G-30
About Us

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. was founded on December 30th 2006. Lonzeal’s current core business is research and development, production and sales of anti-AIDS and hepatitis B drugs. We are now one of the most competitive manufacturers of anti-retrovirus (ARV for HIV and HBV) drugs in China, with product registration at international drug authorities including WHOPQ, China, India, Russia, Brazil and South Africa.

  • CN
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Contact info
Event information
CPHI Japan 2025
  • 09 Apr 2025 – 11 Apr 2025
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand 5G-30

Products Featured at CPHI Japan 2025

  • Baloxavir Marboxil

    Product Baloxavir Marboxil

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Baloxavir Marboxil. Product not provided to where patent is still valid
  • Pregabalin

    Product Pregabalin

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Pregabalin.
  • Emtricitabine

    Product Emtricitabine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Emtricitabine.
  • Lamivudine

    Product Lamivudine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine. It belongs to antiviral drugs APIi category. APIplication: anti-viral drug substance. Contact us for more information.
  • Tenofovir Alafenamide Fumarate(TAF)

    Product Tenofovir Alafenamide Fumarate(TAF)

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes TAF.  Product not provided to where patent is still valid
  • Tenofovir Disoproxil Fumarate (TDF)

    Product Tenofovir Disoproxil Fumarate (TDF)

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes tenofovir disoproxil fumarate (tdf). It belongs to antiviral drugs APIi category. APIplication: anti-viral drug substance. Contact us for more information.
  • Paroxetine Hydrochloride

    Product Paroxetine Hydrochloride

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes paroxetine hydrochloride. APIplication: antidepressant drug substance. Contact us for more information.
  • Lamivudine Intermediate CME

    Product Lamivudine Intermediate CME

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine intermediate cme. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • Lamivudine Intermediate CTS

    Product Lamivudine Intermediate CTS

    Lamivudine Intermediate CTS
  • Lamivudine Intermediate HME

    Product Lamivudine Intermediate HME

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine intermediate hme. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • Lamivudine Intermediate MGH

    Product Lamivudine Intermediate MGH

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine intermediate l-mgh. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • TDF Intermediate PMPA

    Product TDF Intermediate PMPA

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes TDF intermediate pmpa. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • Lamivudine Tablets
  • Pregabalin Capsules

    Product Pregabalin Capsules

    25mg/50mg/75mg/100mg/150mg
  • Tenofovir Alafenamide Fumarate Tablets

    Product Tenofovir Alafenamide Fumarate Tablets

    25mg.  Product not provided to where patent is still valid